Clinical TrialBLAZE-1 (NCT04427501) Clinical Trial BLAZE-1 Clinical TrialStudy DesignEfficacySafety & RequirementsSafety InformationLimitations of Authorized UseImportant Safety InformationHypersensitivity Including Anaphylaxis & Infusion-Related ReactionsLimitations of Benefit & Potential Risk in Patients with Severe COVID-19Adverse EventsUse in Specific Populations
